当前位置: X-MOL 学术 › Diagn Interv Radiol › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Magnetic resonance imaging-guided radiofrequency ablation of breast cancer: a current state of the art review.
Diagnostic and Interventional Radiology Pub Date : 2023-03-24 , DOI: 10.4274/dir.2022.221429
Chuan Zhang 1 , Jing Shi 2 , Bing Li 1 , Xiaoxuan Yu 1 , Xu Feng 1 , Hanfeng Yang 1
Affiliation  

With a gradual increase in breast cancer incidence and mortality rates and an urgent need to improve patient prognosis and cosmetology, magnetic resonance imaging (MRI)-guided radiofrequency ablation (RFA) therapy has attracted wide attention as a new treatment method for breast cancer. MRI-RFA results in a higher complete ablation rate and extremely low recurrence and complication rates. Thus, it may be used as an independent treatment for breast cancer or adjuvant to breast-conserving surgery to reduce the extent of breast resection. Furthermore, with MRI guidance, accurate control of RFA can be achieved, and breast cancer treatment can enter a new stage of minimally invasive, safe, and comprehensive therapy. With progress in MR thermometry technology, the applications of MRI are expected to broaden.

中文翻译:

磁共振成像引导的乳腺癌射频消融术:当前最先进的综述。

随着乳腺癌发病率和死亡率的逐渐升高以及改善患者预后和美容的迫切需要,磁共振成像(MRI)引导的射频消融(RFA)治疗作为一种新的乳腺癌治疗方法受到广泛关注。MRI-RFA 导致更高的完全消融率和极低的复发率和并发症率。因此,它可以作为乳腺癌的独立治疗方法或辅助保乳手术以减少乳房切除的范围。此外,在MRI引导下,可以实现RFA的精准控制,使乳腺癌治疗进入微创、安全、综合治疗的新阶段。随着 MR 测温技术的进步,MRI 的应用有望得到拓宽。
更新日期:2023-03-24
down
wechat
bug